Hematology/Oncology

• FDA approvals

• FDA approves 2-D mammography software

• May 21, 2013
• The FDA today approved the use of new imaging software for use in mammography, according to its manufacturer.
  C-View 2D (Hologic) generates 2-D images from...More »

• In the Journals

• Selective estrogen receptor modulators reduced breast cancer risk up to 5 years

• May 20, 2013
• Treatment with selective estrogen receptor modulators reduced breast cancer incidence by 38% among women at high risk for the disease, according to...More »

• In the Journals

• Review highlights ‘imbalances, distinctions’ within oncology trials

• May 17, 2013
• The manner in which oncology trials are conducted differs significantly from trials conducted in other specialties, according to study results.
  The...More »

• In the Journals

• Risk factors identified for locoregional recurrence in triple-negative breast cancer

• May 16, 2013
• Increasing age and the presence of lymphovascular invasion were among several predictors of locoregional recurrence in a cohort of women with...More »

• In the Journals

• Pregnancy did not affect maternal prognosis of breast cancer

• May 10, 2013
• Women who were diagnosed with breast cancer during pregnancy experienced similar DFS and OS rates as women who were not pregnant, according to study...More »

• FDA public health advisories

• FDA: Confusion between names of breast cancer drugs may cause medication errors

• May 6, 2013
• Incorrect use of the non-proprietary name for a newly approved breast cancer therapy in electronic medical record systems may cause confusion that results...More »

• In the Journals

• Breast cancer survivors not meeting minimum exercise recommendations

• May 6, 2013
• Nearly four of every five breast cancer survivors do not meet national exercise recommendations 10 years after their diagnosis, study results showed.
  At...More »

• Meeting News Coverage

• IMRT showed fewer adverse effects than standard radiotherapy

• May 3, 2013
• Intensity-modulated radiotherapy reduced adverse effects of radiation in patients with early breast cancer, according to results presented at the 2nd...More »

• Cover Stories

• Nanoparticles offer ‘infinite’ possibilities for cancer treatment

• HemOnc Today, May 10, 2013
• After more than 3 decades of intense research, nanotechnology has moved out of the fiction realm and into the scientific.
  Preliminary data suggest...More »

• In the Journals

• Gemcitabine/paclitaxel improved PFS, OS in metastatic breast cancer

• April 30, 2013
• Maintenance therapy with paclitaxel and gemcitabine improved PFS and OS in women with metastatic breast cancer who initially exhibited disease control...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!